Skip to main content
. 2023 Nov 10;14:1152514. doi: 10.3389/fendo.2023.1152514

Figure 3.

Figure 3

Survival analysis between Cutibacterium High and low burden subgroups (A) Overall survival (n=27) in anaplastic thyroid cancer (B) Progression free survival (n=25) in anaplastic thyroid cancer (C) Progression free survival (n=9) in papillary thyroid cancer.